Assessment of response to endocrine therapy using FDG PET/CT in metastatic breast cancer: a pilot study.
| Publicado en: | European Journal of Nuclear Medicine & Molecular Imaging Vol. 39; no. 3; pp. 450 - 461 |
|---|---|
| Autores principales: | , , , , , , , , , |
| Formato: | Journal Article |
| Publicado: |
Springer Nature
Mar2012
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=104327239&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 104327239 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 16197070 NPC jtl: European Journal of Nuclear Medicine & Molecular Imaging issn: 16197070 maglogo: N pubinfo: dt: Mar2012 vid: 39 iid: 3 pid: 237 pub: Springer Nature place: New York, New York artinfo: ui: 104327239 2011948493 10.1007/s00259-011-1981-z 104327239 ppf: 450 ppct: 11 formats: fmt: @attributes: type: P tig: atl: Assessment of response to endocrine therapy using FDG PET/CT in metastatic breast cancer: a pilot study. aug: au: Mortazavi-Jehanno, Nina Giraudet, Anne-Laure Champion, Laurence Lerebours, Florence Stanc, Elise Edeline, Veronique Madar, Olivier Bellet, Dominique Pecking, Alain Alberini, Jean-Louis affil: Service de Médecine nucléaire, Institut Curie, Hôpital René Huguenin, 35 rue Dailly 92210 Saint-Cloud France sug: pubtype: Academic Journal doctype: Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|